Russell Kern
Lineage Cell Therapeutics (United States)(US)Io Therapeutics (United States)(US)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, Biomedical Ethics and Regulation, Neurological disorders and treatments, Osteoarthritis Treatment and Mechanisms, Nuclear Receptors and Signaling
Most-Cited Works
- → Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease(2016)74 cited
- → Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease(2016)73 cited
- → Novel Approach to Stem Cell Therapy in Parkinson's Disease(2018)46 cited
- → Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model(2019)36 cited
- → Derivation of Neural Stem Cells from Human Parthenogenetic Stem Cells(2019)9 cited
- → Supplementation of specific carbohydrates results in enhanced deposition of chondrogenic-specific matrix during mesenchymal stem cell differentiation(2018)6 cited
- → Results of an Open Label, Dose Escalating, Phase 1 Clinical Trial Evaluating the Safety of a Human Neural Stem Cell Based Therapy in Parkinson’s Disease (P1.8-016)(2019)3 cited
- → Interim Clinical Assessment of a Neural Stem Cell Based Therapy for Parkinson’s Disease (S26.002)(2018)1 cited
- → PRELIMINARY RESULTS OF THE PHASE I CLINICAL STUDY EVALUATING NEURAL STEM CELL BASED THERAPY FOR PARKINSON’S DISEASE (S4.004)(2017)
- → Cover Image, Volume 12, Issue 5(2018)